357 related articles for article (PubMed ID: 29488270)
1. Evolution of diagnostic criteria and assessments for Parkinson's disease mild cognitive impairment.
Goldman JG; Holden SK; Litvan I; McKeith I; Stebbins GT; Taylor JP
Mov Disord; 2018 Apr; 33(4):503-510. PubMed ID: 29488270
[TBL] [Abstract][Full Text] [Related]
2. [Mild cognitive impairment in Parkinson's disease].
Wada K; Nakashima K
Brain Nerve; 2012 Dec; 64(12):1365-75. PubMed ID: 23209063
[TBL] [Abstract][Full Text] [Related]
3. Mild cognitive impairment: an update in Parkinson's disease and lessons learned from Alzheimer's disease.
Goldman JG; Aggarwal NT; Schroeder CD
Neurodegener Dis Manag; 2015 Oct; 5(5):425-43. PubMed ID: 26517759
[TBL] [Abstract][Full Text] [Related]
4. Risk of Parkinson's disease dementia related to level I MDS PD-MCI.
Hoogland J; Boel JA; de Bie RMA; Schmand BA; Geskus RB; Dalrymple-Alford JC; Marras C; Adler CH; Weintraub D; Junque C; Pedersen KF; Mollenhauer B; Goldman JG; Tröster AI; Burn DJ; Litvan I; Geurtsen GJ;
Mov Disord; 2019 Mar; 34(3):430-435. PubMed ID: 30653248
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines.
Litvan I; Goldman JG; Tröster AI; Schmand BA; Weintraub D; Petersen RC; Mollenhauer B; Adler CH; Marder K; Williams-Gray CH; Aarsland D; Kulisevsky J; Rodriguez-Oroz MC; Burn DJ; Barker RA; Emre M
Mov Disord; 2012 Mar; 27(3):349-56. PubMed ID: 22275317
[TBL] [Abstract][Full Text] [Related]
6. Assessing the utility of the Movement Disorder Society Task Force Level 1 diagnostic criteria for mild cognitive impairment in Parkinson's disease.
Szeto JY; Mowszowski L; Gilat M; Walton CC; Naismith SL; Lewis SJ
Parkinsonism Relat Disord; 2015 Jan; 21(1):31-5. PubMed ID: 25465744
[TBL] [Abstract][Full Text] [Related]
7. An assessment of Movement Disorder Society Task Force diagnostic criteria for mild cognitive impairment in Parkinson's disease.
Uysal-Cantürk P; Hanağası HA; Bilgiç B; Gürvit H; Emre M
Eur J Neurol; 2018 Jan; 25(1):148-153. PubMed ID: 28941002
[TBL] [Abstract][Full Text] [Related]
8. Mild cognitive impairment in Parkinson's disease: Diagnosis and progression to dementia.
Galtier I; Nieto A; Lorenzo JN; Barroso J
J Clin Exp Neuropsychol; 2016; 38(1):40-50. PubMed ID: 26602176
[TBL] [Abstract][Full Text] [Related]
9. Defining optimal cutoff scores for cognitive impairment using Movement Disorder Society Task Force criteria for mild cognitive impairment in Parkinson's disease.
Goldman JG; Holden S; Bernard B; Ouyang B; Goetz CG; Stebbins GT
Mov Disord; 2013 Dec; 28(14):1972-9. PubMed ID: 24123267
[TBL] [Abstract][Full Text] [Related]
10. MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI.
Litvan I; Aarsland D; Adler CH; Goldman JG; Kulisevsky J; Mollenhauer B; Rodriguez-Oroz MC; Tröster AI; Weintraub D
Mov Disord; 2011 Aug; 26(10):1814-24. PubMed ID: 21661055
[TBL] [Abstract][Full Text] [Related]
11. Characterizing Cognitive Impairment in Parkinson's Disease.
Bailey M; Goldman JG
Semin Neurol; 2017 Apr; 37(2):167-175. PubMed ID: 28511257
[TBL] [Abstract][Full Text] [Related]
12. Neuroimaging correlates of cognitive impairment and dementia in Parkinson's disease.
Mak E; Su L; Williams GB; O'Brien JT
Parkinsonism Relat Disord; 2015 Aug; 21(8):862-70. PubMed ID: 26004683
[TBL] [Abstract][Full Text] [Related]
13. Mild cognitive impairment as a risk factor for Parkinson's disease dementia.
Hoogland J; Boel JA; de Bie RMA; Geskus RB; Schmand BA; Dalrymple-Alford JC; Marras C; Adler CH; Goldman JG; Tröster AI; Burn DJ; Litvan I; Geurtsen GJ;
Mov Disord; 2017 Jul; 32(7):1056-1065. PubMed ID: 28605056
[TBL] [Abstract][Full Text] [Related]
14. Diagnosing mild cognitive impairment in Parkinson's disease: which tests perform best in the Italian population?
Federico A; Trentin M; Zanette G; Mapelli D; Picelli A; Smania N; Tinazzi M; Tamburin S
Neurol Sci; 2017 Aug; 38(8):1461-1468. PubMed ID: 28550344
[TBL] [Abstract][Full Text] [Related]
15. Parkinson's disease mild cognitive impairment: application and validation of the criteria.
Geurtsen GJ; Hoogland J; Goldman JG; Schmand BA; Tröster AI; Burn DJ; Litvan I;
J Parkinsons Dis; 2014; 4(2):131-7. PubMed ID: 24296865
[TBL] [Abstract][Full Text] [Related]
16. Strengths and challenges in conducting clinical trials in Parkinson's disease mild cognitive impairment.
Litvan I; Kieburtz K; Tröster AI; Aarsland D
Mov Disord; 2018 Apr; 33(4):520-527. PubMed ID: 29573469
[TBL] [Abstract][Full Text] [Related]
17. Initial cognitive changes in Parkinson's disease.
Weintraub D; Tröster AI; Marras C; Stebbins G
Mov Disord; 2018 Apr; 33(4):511-519. PubMed ID: 29543342
[TBL] [Abstract][Full Text] [Related]
18. Cognitive impairment in Parkinson's disease is multifactorial: A neuropsychological study.
Smith CR; Cullen B; Sheridan MP; Cavanagh J; Grosset KA; Grosset DG
Acta Neurol Scand; 2020 Jun; 141(6):500-508. PubMed ID: 32002988
[TBL] [Abstract][Full Text] [Related]
19. Cognitive Impairments in Parkinson's disease.
Nakashima K
Nihon Rinsho; 2017 Jan; 75(1):101-104. PubMed ID: 30566302
[TBL] [Abstract][Full Text] [Related]
20. [Subtypes of mild cognitive impairment in Parkinson's disease and factors predicting its becoming dementia].
Toribio-Diaz ME; Carod-Artal FJ
Rev Neurol; 2015 Jul; 61(1):14-24. PubMed ID: 26108904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
